Drug Guide
Famotidine
Classification
Therapeutic: Gastrointestinal agent, Acid reducer
Pharmacological: Histamine-2 (H2) receptor antagonist
FDA Approved Indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease (gastric and duodenal ulcers)
- Erozive esophagitis
- Pathologic hypersecretory conditions (e.g., Zollinger-Ellison syndrome)
Mechanism of Action
Famotidine selectively inhibits histamine at H2 receptors of gastric parietal cells, decreasing gastric acid secretion.
Dosage and Administration
Adult: Typically 20 mg once or twice daily; doses may vary based on condition and response.
Pediatric: Generally 0.5-1 mg/kg twice daily for children, but dose should be individualized and guided by a pediatrician.
Geriatric: Same as adult, but consider renal function and adjust dosage accordingly.
Renal Impairment: Dose adjustment recommended, usually to 20 mg once daily or less, depending on severity.
Hepatic Impairment: Use with caution; no specific dose adjustment recommended but monitor closely.
Pharmacokinetics
Absorption: Well absorbed, with peak plasma concentrations in 1-3 hours.
Distribution: Widely distributed, crosses the placenta, minimal protein binding.
Metabolism: Negligible hepatic metabolism.
Excretion: Primarily excreted unchanged in urine.
Half Life: 2.5-4 hours.
Contraindications
- Hypersensitivity to famotidine or other H2 antagonists.
Precautions
- Use with caution in renally impaired patients.
- Monitor for GI infections due to reduced acidity.
- Pregnancy Category B; consult healthcare provider before use during pregnancy.
- Lactation: consider benefits vs. risks; famotidine passes into breast milk.
Adverse Reactions - Common
- Headache (Uncommon)
- Dizziness (Uncommon)
- Constipation or diarrhea (Uncommon)
Adverse Reactions - Serious
- CNS effects (confusion, agitation) particularly in elderly or renally impaired (Rare)
- Cardiovascular reactions (arrhythmias) (Rare)
- Allergic reactions (rash, anaphylaxis) (Rare)
Drug-Drug Interactions
- Cimetidine (increases famotidine levels)
Drug-Food Interactions
- No significant food interactions noted.
Drug-Herb Interactions
- Use caution with herbs affecting gastric pH or cytochrome P450 enzymes.
Nursing Implications
Assessment: Monitor for relief of symptoms, assess for adverse reactions, and renal function.
Diagnoses:
- Risk for GI infections related to decreased gastric acidity.
- Impaired comfort related to GERD.
Implementation: Administer as prescribed, monitor renal function, educate on timing with meals and other meds.
Evaluation: Assess symptom relief and monitor for adverse effects.
Patient/Family Teaching
- Take famotidine exactly as prescribed.
- Report any signs of allergic reactions or CNS effects.
- Do not crush or chew sustained-release formulations.
- Notify healthcare provider if symptoms persist or worsen.
Special Considerations
Black Box Warnings:
- No black box warnings for famotidine.
Genetic Factors: Limited data; genetic polymorphisms unlikely to significantly impact famotidine action.
Lab Test Interference: May interfere with assessment of urinary pH.
Overdose Management
Signs/Symptoms: Drowsiness, tachycardia, or mental status changes may occur.
Treatment: Supportive care; activated charcoal if ingestion is recent; hemodialysis in severe cases.
Storage and Handling
Storage: Store at room temperature, 20-25°C (68-77°F).
Stability: Stable for the duration of the labeled shelf life.